Printer Friendly

Polysaccharide extract of Mimosa tenuiflora stem barks stimulates acute inflammatory response via nitric oxide/Extrato polissacaridico oriundo das cascas do caule de Mimosa tenuiflora induz resposta inflamatoria aguda via oxido nitrico.


Mimosa tenuiflora (Wild.) Poiret (Mimosaceae) is a plant commonly found in the northeast Brazil, where is popularly known as "jurema-preta" (Oliveira, Chiavone-Filho, Rodrigues & Medeiros, 1999). The bark powder is used in folk medicine to treat skin burns, wounds and inflammation (Grether, 1988; Camargo-Ricalde, Grether, & Martinez-Bernal, 1994). In vivo experiments demonstrated the healing effect in human venous ulceration of the alcoholic extracts from M. tenuiflora cortex (Rivera-Arce et al., 2006) and the antinociceptive and anti-inflammatory activities of its barks (Cruz et al., 2016). In vitro, arabinogalactans (5 to 140 kDa) isolated from M. tenuiflora stimulates fibroblast and keratinocyte proliferation (Zippel, Deters, & Hensel, 2009). Besides, polysaccharides derived from higher plants are recognized for their relative nontoxicity, being ideal candidates for immunomodulatory, anti-tumor and wound-healing therapies (Meng et al., 2014; Pereira et al., 2012a; Zhou, Shi, Jiang, Zhou, & Xu, 2014; Lazareva et al., 2002). The aim of this study was to evaluate the inflammatory response of the polysaccharides extracted from M. tenuiflora stem barks in models of acute inflammation in rats.

Material and methods

Plant material

Barks of M. tenuiflora were collected directly in nature, in the District of Daniel de Queiroz-Quixada, Ceara, Brazil. The plant was identified by the biologist Regis C. Paulino and its exsiccate (no. 46085) was deposited at the Botanical Laboratory (Universidade Estadual do Ceara) and Herbarium Prisco Bezerra (Universidade Federal do Ceara).


N-Nitro-L-arginine methyl ester hydrochloride (L-NAME), D-galactose, bovine serum albumin (BSA), Coomassie brilliant blue, G-250, formamide and Evans blue were obtained from Sigma Chemical-Aldrich (St. Louis, MO, USA); dexamethasone and indomethacin were from Prodome Quimica e Farmaceutica, Campinas, SP (Brazil). EP-Mt and drugs were solubilized in sterile saline (0.9% NaCl), except for indomethacin, which was dissolved in 10% dimethyl sulfoxide (DMSO).


Wistar rats (150-250 g) were maintained under 12/12 h light/dark cycle, at 25[degrees]C, with free access of food and water. Experimental protocols were in compliance with the Guide for the Care and Use of Laboratory Animals of the US Department of Health and Human Services (NIH no. 85-23, 1985) and approved (no. 10130208-8/40) by the Animal Care and Use Committee of the Universidade Estadual do Ceara, Brazil.

Polysaccharide extraction

Mimosa tenuiflora stem barks were washed with distilled water, dried at 40[degrees]C, grounded into powder (5 g), suspended in methanol (1:50, w/v, 60[degrees]C) and filtered to remove methanol-soluble material (repeated two times). The insoluble portion was extracted in 0.1 M NaOH at 90[degrees]C and centrifuged (2496 x g; r.t.) (repeated three times). The alkaline extracts were pooled, neutralized with 1 M HCl, precipitated with four volumes of ethanol and centrifuged. The pellet was dialyzed (membrane cut-off 14 kDa; 72 h) against running water, centrifuged (2496 x g; r.t.), the final supernatant lyophilized (Pereira et al., 2012a) and named extract polysaccharide of M. tenuiflora (EP-Mt).

Chemical analysis

The content of carbohydrate (Dubois, Gilles, Hamilton, Rebers, & Smith, 1956) and protein (Bradford, 1976) of EP-Mt was assessed by spectrophotometry, using D-galactose ([A.sub.490] nm) and BSA ([A.sub.595] nm), respectively, as standards.

Inflammation models

Paw edema was induced by subcutaneous (s.c.) intraplantar injection of EP-Mt (0.01, 0.1 and 1 mg [kg.sup.-1]) as inflammatory stimulus. Control animals received sterile saline (0.9% NaCl). Dexamethasone (5 mg [kg.sup.-1]) or L-NAME (25 mg [kg.sup.-1]) was injected by intravenous route (i.v.) 30 min prior to EP-Mt. The edema was measured by plethysmometry (Panlab LE-7500) before edema induction (zero time), at 30 min, and from 60 to 420 min thereafter, and expressed in [micro]L or area under the curve-AUC (arbitrary units) (Landucci et al., 1995). For evaluation of plasma leakage, animals received Evans blue (25 mg [kg.sup.-1]) 30 min before edema induction by EP-Mt. The paws were excised, incubated with 1 mL formamide (37[degrees]C, 72 hours) and the increase in vascular permeability assessed by spectrophotometry ([A.sub.600] nm). Data was expressed in pg Evans blue/g paw wet weight using linear regression based on Evans blue standard curve (Wilhelm, 1982).

Peritonitis was induced by intraperitoneal (i.p.) injection of EP-Mt (1 mg [kg.sup.-1]; 500 [micro]L) and evaluated 180 min later. After sacrifice, peritoneal cells were harvested with 3 mL phosphate-buffered saline (PBS) containing heparin (5 IU) for total and differential leukocyte counts. Results were expressed as the number of peritoneal leukocytes (x [10.sup.3] [mL.sup.-1]). Animals received saline (i.v.), dexamethasone (5 mg [kg.sup.-1]; i.v.), L-NAME (25 mg [kg.sup.-1]; i.v.) or indomethacin (10 mg [kg.sup.-1]; i.v.) 30 min before stimulation with EP-Mt. Vascular permeability was quantified by protein dosage of the peritoneal fluid (Bradford, 1976).

The activity of mieloperoxidase (MPO) was measured in peritoneal fluid collected 180 min after stimulation. The samples were homogenized, mixed with 0-dianisidine dihydrochloride (0.167 mg [mL.sup.-1] in 50 mM phosphate buffer), containing [H.sub.2][O.sub.2] (0.005%) and measured at [A.sub.460] nm. Results were expressed as units of MPO (UMPO [mL.sup.-1]). One unit of MPO was defined as the conversion of 1 [micro]mol of hydrogen peroxide to water in 1 min at 22[degrees]C (Bradley, Chritensen, & Rothstein, 1982).

Statistical analysis

Results were expressed as mean [+ or -] S.E. M. (n=6) and analyzed by One-way/Two-way ANOVA and Bonferroni test (Prism 5.0, GraphPad Software Inc., California, USA). Differences were considered for p [less than or equal to] 0.05.

Results and Discussion

The brown colored polysaccharide extract of M. tenuiflora stem barks (EP-Mt) yielded 3.8%, higher than those obtained from Caesalpinia ferrea pods (2.8%) (Pereira et al., 2012a) and Azadirachta indica teguments (1.3%), extracted by similar procedures (Pereira, Silva, Silva, Assreuy, & Pereira, 2012b). Yield variations of polysaccharide extraction can be explained by the changes in their distribution in plant parts and also by the type of extraction employed (Gottlieb & Borin, 2004). EP-Mt revealed high content of carbohydrate (41%), which was superior in comparison with that obtained from C. ferrea (31%) (Pereira et al., 2012a) and Erigeron canadensis flowers (34.1%) (Pawlaczyk et al., 2011). Importantly, the protein content (0.34%) was much less compared to the polysaccharides of Geoffroea spinosa barks (9%) (Silva et al., 2015), C. ferrea (3%) (Pereira et al., 2012a) and A. indica (4%) (Pereira et al., 2012b), both extracted by the same protocol. The low content of protein and high content of carbohydrate are justified by the conditions of polysaccharide extraction: high temperature, depigmentation by methanol, alkaline extraction and precipitation with ethanol (Yoon et al., 2002, Pereira et al., 2012a).

Although in the present study the analysis of phenolic compounds had not been assessed, in other study performed with M. tenuiflora barks, the presence of these compounds (minor residual amounts) was observed in the total polysaccharide extract. It is important to note that the authors could correlate the presence of phenolic compounds with the toxicity observed in cultured skin fibroblasts. Such effect was abolished after removal of the phenolic compound, which was associated to the polysaccharide (Zippel et al., 2009). In addition, previous phytochemical studies demonstrated presence of phenolic compounds (Jiag et al., 1991; Rivera-Arce et al., 2007), saponin, alkaloids, glucose, xylose, rhamnose, arabinose, lupeol, phytosterols, lipids, calcium oxalate crystals and starch (Jiag et al., 1991) in M. tenuiflora barks.

EP-Mt evoked paw edema in rats at all doses tested (0.01, 0.1 and 1 mg [kg.sup.-1]), showing a time course that was initiated at 30 min being maximal at 180 min. At 0.01 and 0.1 mg [kg.sup.-1] the edema lasted up to 240 min and at 1 mg [kg.sup.-1] up to 420 min (Figure 1A). The area under the edema time-course curve (AUC) showed that EP-Mt increased paw volume in 10 fold at 0.01 mg [kg.sup.-1] (AUC: 26.9 [+ or -] 3.5) and 0.1 mg [kg.sup.-1] (25.3 [+ or -] 0.7), while at 1 mg [kg.sup.-1] the paw edema increase was about 40 fold (AUC: 102.5 [+ or -] 9.3) compared to saline (AUC: 2.5 [+ or -] 0.9 arbitrary units) (Figure 1B). The edematogenic effect of EP-Mt (1 mg [kg.sup.-1]) was inhibited mainly by L-NAME (52%) and by dexamethasone (26%) (Figure 1C).

In the peritonitis model, EP-Mt (1.0 mg [kg.sup.-1], i.p.) increased the number of total leukocytes in 2.2 fold (6.980 [+ or -] 0.707 vs. saline: 3.140 [+ or -] 0.531 x [10.sup.3] [mL.sup.-1]), mainly neutrophils in 6.5 fold (4.648 [+ or -] 0.467 vs. saline: 0.705 [+ or -] 0.158 x [10.sup.3] [mL.sup.-1]) (Figure 2A). EP-Mt also increased MPO activity by 96% (14.3 [+ or -] 3.1 vs. saline: 4.9 [+ or -] 0.8 UMPO [mL.sup.-1]) (Figure 2B), an enzyme highly expressed in neutrophils that has been associated with the nitric oxide (NO) bioavailability (Galijasevic, 2013). Accordingly, the pre-treatment with L-NAME (nitric oxide synthase inhibitor) reduced EP-Mt leukocyte migration by 38% (5.683 [+ or -] 0.481 x [10.sup.3] [mL.sup.-1]). In addition, the 0treatment of animals with dexamethasone (a nonspecific anti-inflammatory glucocorticoid) 180 min after EP-Mt administration, significantly reduced leukocyte migration by 39% (5.584 [+ or -] 0.193 x [10.sup.3] [mL.sup.-1]). On the other hand, indomethacin (cyclooxygenase inhibitor) did not alter the leukocyte migration elicited by EP-Mt (Figure 2C).

The vascular permeability evaluated by Evans blue leakage at 30 min in the paw edema model was not altered, indicating that EP-Mt edematogenic effect is not of osmotic nature, different from that elicited by the polysaccharide dextran (Lo, Almeida, & Beaven, 1982). This data was confirmed by the lack of alteration in vascular permeability, seen by the protein dosage by the Bradford method evaluated at 180 min after peritonitis induction (Table 1).

In acute inflammatory processes, macrophages, mast cells and lymphocytes have a modulator role in neutrophil migration releasing chemotactic factors, such as leukotrienes ([LTB.sub.4]) and cytokines: tumor necrosis factor-alpha (TNF-[alpha]) and interleukin 1 (IL-1) (Ranki, Sylvester, Smith, Yoshimura, & Leonard, 1990). The inhibitory effect of dexamethasone on EP-Mt chemotactic effect could be explained by the blockage of leukotrienes and/or cytokines release. Besides, the anti-inflammatory mechanism of dexamethasone includes the inhibition of the expression of various inflammatory genes, such as that of the inducible nitric oxide synthase (iNOS), leading to decreased production of NO (Korhonen, Lahti, Hamalainen, Kankaanranta, & Moilanen, 2002; Secco et al., 2006; Moncada, Palmer, & Higgs, 1991). This data reinforces the inhibitory effect of L-NAME on the neutrophil migration stimulated by EP-Mt. Prostaglandins are mediators that also play a complex role in primary aspects of acute inflammatory response, such as pain, neutrophil migration, swelling and plasma exudation (Menezes et al., 2008). Our data demonstrated that the pre-treatment of animals with indomethacin did not alter the leukocyte migration, suggesting that prostaglandins are not crucial for the occurrence of leukocyte migration elicited by EPMt. In addition, it is possible to suggest that EP-Mt stimulates neutrophil chemotaxis, rather than vascular permeability. Furthermore, although not detected at the time-points evaluated in the peritonitis model, the possible EP-Mt effect in permeability could occur prior to its neutrophil chemotactic effect, which partially explains the inhibitory effect of L-NAME.

The effect of polysaccharides of higher plants in leukocytes, via macrophage activation, is extensively described in literature (Park et al., 2001; Sugawara, Lee, & Wong, 1984; Schepetkin, Faulkner, Nelson-Overton, Wiley, & Quinn, 2005; Schepetkin & Quinn, 2006). It has been shown that these compounds might stimulate macrophage phagocytic and cytotoxic activities against tumoral cells and micro-organisms, production of reactive oxygen species (ROS), and secretion of cytokines and chemokines. The polysaccharide of Juniperus scopolorum showed potent immunostimulant effect, via increase of NO production and release of proinflammatory cytokines by macrophages (IL-1, IL-6, TNF-[alpha]) (Schepetkin et al, 2005). In addition, the polysaccharide obtained from Dendobrium officinal raised macrophage levels of TNF-[alpha], IL-1[beta] (He et al., 2016) and NO production (Xia et al., 2012). Based on these, we believe that EP-Mt might stimulate leukocytes to release chemotactic substances, being considered a promisor candidate to be used in immunostimulant therapies.


The results reported in the present study clearly demonstrate that the polysaccharides extracted from M. tenuiflora stem barks, possessing high content of carbohydrate, elicit acute inflammation with the involvement of nitric oxide. It is worth mentioning the necessity to investigate molecules from natural sources presenting immunomodulatory effect, aiming the development of novel therapeutic agents for being used in pathological conditions of the immune system.

Doi: 10.4025/actascibiolsci.v38i4.32234


This research was supported by CAPES, CNPq and FUNCAP. Ana Maria S. Assreuy is a senior investigator of CNPq.


Bradford, M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry, 72(2), 248-254.

Bradley, P. P., Christensen, R. D., & Rothstein, G. (1982). Cellular and extracellular myeloperoxidase in pyogenic inflammation. Blood, 60(3), 618-622.

Camargo-Ricalde, R., Grether, A., & Martinez-Bernal, S. L. (1994). Uso medicinal del "tepescohuite" Mimosa tenuiflora (Leguminosae) en Mexico. Contactos, 5(1), 29-34.

Cruz, M. P., Andrade, C. M. F., Silva, K. O., de Souza, E. P., Yatsuda, R., Marques, L. M., ... Clemente Napimoga, J. (2016). Antinoceptive and antiinflammatory activities of the ethanolic extract, fractions and flavones isolated from Mimosa tenuiflora (Willd.) Poir (Leguminosae). PLoS One, 11(3), 1-26.

Dubois, M., Gilles, K. A., Hamilton, J. K., Rebers, P. A., & Smith F. (1956). Colorimetric method for determination of sugars and related substances. Analytical Chemistry, 28(3), 350-356.

Galijasevic, S. (2013). Myeloperoxidase interactions with nitric oxide: A review of mechanistic pathways. Bulletin of the Chemists and Technologists of Bosnia and Herzegovina, 40, 1-8.

Gottlieb, O. R., & Borin, M. R. M. B. (2004). Quimiossistematica como ferramenta na busca de substancias ativas. In C. M. O. Simoes (Ed.). Farmacognosia: da planta ao medicamento (p. 91-105). Porto Alegre/Santa Catarina: UFGRS/UFSC.

Grether, R. (1988). Nota sobre la identidad del tepescohuite en Mexico. Boletin de la Sociedad Botanica de Mexico, 48(1), 151-152.

He, T., Huang, Y., Yang, L., Liu, T., Gong, W., Wang, X., & Hu, J. (2016). Structural characterization and immunomodulating activity of polysaccharide from Dendrobium officinale. International Journal of Biological Macromolecules, 83, 34-41.

Jiag, Y., Haag-Berrurier, M. R., Anton, R., Massiot, G., Lavaud, C., & Teulon, J. M. (1991). Structure of a new saponin from the bark of Mimosa tenuiflora. Journal of Natural Products, 54(5), 1247-1253.

Korhonen, R., Lahti, A., Hamalainen, M., Kankaanranta, H., & Moilanen, E. (2002). Dexamethasone inhibits inducible nitric-oxide synthase expression and nitric oxide production by destabilizing mRNA in Lipopolysaccharide-treated macrophages. Molecular Pharmacology, 62(3), 698-704.

Landucci, E. C., Antunes, E., Donato, J. L., Faro, R., Hyslop, S., Marangoni, S., ... De Nucci, G. (1995). Inhibition of carrageenan--induced rat paw oedema by crotapotin, a polypeptide complexed with phospholipase A2. British Journal of Pharmacology, 114(3), 578-583

Lazareva, E. B., Spiridonova, T. G., Chernega, E. N., Plesskaia, L. G., Grunenkova, I. V., Smirnov, S.V, & Men'shikov, D. D. (2002). Topical pectins for the treatment of burn wounds. Antibiot Khimioter, 47(9), 913.

Lo, T. N., Almeida, A. P., & Beaven, M. A. (1982). Dextran and carrageenan evoke different inflammatory response in rat with respect to composition of infiltrates and effect of indomethacin. Journal of Pharmacology and Experimental Therapeutics, 221(1), 261-267.

Menezes, G. B., Rezende, R. M., Pereira-Silva, P. E., Klein, A., Cara, D. C., & Francischi, J. N. (2008). Differential involvement of cyclooxygenase isoforms in neutrophil migration in vivo and in vitro. European Journal of Pharmacology, 598(1-3), 118-122.

Meng, F. Y., Ning, Y. L., Qi, J., He, Z., Jie, J., Lin, J. J., & Li, X. H. (2014). Structure and antitumor and immunomodulatory activities of a water-soluble polysaccharide from Dimocarpus longan Pulp. International Journal of Molecular Sciences, 15(3), 5140-5162.

Moncada, S., Palmer, R. M. J., & Higgs, E. A. (1991). Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacological Reviews, 43(2), 109-142.

Oliveira, M. R., Chiavone-Filho, O., Rodrigues, J. M. E., & Medeiros, J. T. N. (1999). Estudo das condicoes de cultivo da algaroba e jurema preta e determinacao do poder calorifico. Ciencia e Tecnologia, 14(7), 93-104.

Park, K. M., Kim, Y. S., Jeong, T. C., Joe, C. O., Shin, H. J., & Lee, Y. H. (2001). Nitric oxide is involved in the immunomodulating activities of acidic polysaccharide from Panaxginseng. Planta Medica, 67(2), 122-126.

Pawlaczyk, I., Czerchawski, L., Kuliczkowski, W., Karolko, B., Pilecki, W., Witkiewicz, W., & Gancarz, R. (2011). Anticoagulant and anti-platelet activity of polyphenolic-polysaccharide preparation isolated from the medicinal plant Erigeron canadensis L. Thrombosis Research, 127(4), 328-340.

Pereira, L. P., Silva, K. E. S., Silva, R. O., Assreuy, A. M. S., & Pereira, M. G. (2012b). Anti-inflammatory polysaccharides of Azadirachta indica seed tegument. Revista Brasileira de Farmacognosia, 22(3), 617-622.

Pereira, L. P., Silva, R. O., Bringel, P. H. S. F., Silva, K. E. S., Assreuy, A. M. S., & Pereira, M. G. (2012a). Polysaccharide fractions of Caesalpinia ferrea pods: Potential anti-inflammatory usage. Journal of Ethnopharmacology, 139(2), 642-648.

Ranki, J. A., Sylvester, I., Smith, S., Yoshimura, T., & Leonard, E. J. (1990). Macrophages cultured in vitro release leukotriene B4 and neutrophil attractant activation protein (interleukin-8) sequentially in response to stimulation with lipopolysaccharide and zymosan. Journal of Clinical Investigation, 86(5), 1554-1564.

Rivera-Arce, E., Gattuso, M., Alvarado, R., Zarate, E., Aguero, J., Feria, I., & Lozoya, X. (2007). Pharmacognostical studies of the plant drug Mimosae tenuiflorae cortex. Journal of Ethnopharmacology, 113(3), 400-408.

Rivera-Arce, E., Soto, M. A. C., Arellano, A. H., Arzate, S., Aguero, J., Romero, I. A. F., Lozoya, X. (2006). Therapeutic effectiveness of a Mimosa tenuiflora cortex extract in venous ulceration treatment. Journal of Ethnopharmacology, 109(3), 523-528.

Schepetkin, I. A., & Quinn, M. T. (2006). Botanical polysaccharides: Macrophage immunomodulation and therapeutic potential. International Immunopharmacology, 6(3), 317-33.

Schepetkin, I. A., Faulkner, C. L., Nelson-Overton, L. K., Wiley, J. A., & Quinn, M. T. (2005). Macrophage immunomodulatory activity of polysaccharides isolated from Juniperus scopolorum. International Immunopharmacology, 5(13-14), 1783-1799.

Secco, D. D., Moreira, A., Freitas, A., Silva, J., Rossi, M., Ferreira, S., & Cunha F. (2006). Nitric oxide inhibits neutrophil migration by a mechanism dependent on ICAM-1: Role of soluble guanylate cyclase. Biological Chemistry, 15(1), 77-86.

Silva, R. O., Assreuy, A. M. S., Madeira, J. C., Chagas, F. D. S., Parreira, L. A., Santos, G. R. C., & Pereira, M. G. (2015). Purified polysaccharides of Geoffroea spinosa barks have anticoagulante and antithrombotic activities devoid of hemorrhagic risks. Carbohydrate Polymers, 124, 208-215.

Sugawara, I., Lee, K. C, & Wong, M. (1984). Schizophyllan (SPG)-treated macrophages and antitumor activities against syngeneic and allogeneic tumor cells: I. Characteristics of SPG-treated macrophages. Cancer Immunology, Immunotherapy, 16(3), 137-144.

Wilhelm, D. L. (1982). Patologia (7th ed.). Rio de Janeiro, RJ: Guanabara Koogan.

Xia, L., Liu, X., Guo, H., Zhang, H., Zhu, J. & Ren, F. (2012). Partial characterization and immunomodulatory activity of polysaccharides from the stem of Dendrobium officinale (Tiepishihu) in vitro. Journal of Functional Foods, 4(1), 294-301.

Yoon, S. J., Pereira, M. S., Pavao, M. S. G., Hwang, J. K., Pyun, Y. R., & Mourao, P. A. S. (2002). The medicinal plant Porana volubilis contains polysaccharides with anticoagulant activity mediated by heparin cofactor II. Thrombosis Research, 106(1), 51-58.

Zhou, X., Shi, H., Jiang, G., Zhou, Y., & Xu, J. (2014). Antitumor activities of ginseng polysaccharide in C57BL/6 mice with Lewis lung carcinoma. Tumor Biology, 35(12), 12561-12566.

Zippel, J., Deters, A., & Hensel, A. (2009). Arabinogalactans from Mimosa tenuflora (Willd.) Poiret bark as active principles for wound-healing properties: Specific enhancement of dermal fibroblast activity and minor influence on HaCaT keratinocytes. Journal of Etnopharmacology, 124(3), 391-396.

Received on June 10, 2016.

Accepted on October 26, 2016.

Kaira Emanuella Sales da Silva-Leite (1), Cinthia Silva Queiroz (2), Juliana da Costa Madeira (1), Pedro Marcos Gomes Soares (3), Maria Goncalves Pereira (1,2) and Ana Maria Sampaio Assreuy (1)

(1) Instituto Superior de Ciencias Biomedicas, Universidade Estadual do Ceara, Av. Paranjana, 1700, 60714-903, Fortaleza, Ceara, Brazil. (2) Faculdade de Educacao, Ciencias e Letras do Sertao Central, Universidade Estadual do Ceara, Quixada, Ceara, Brazil. (3) Instituto de Fisiologia e Farmacologia, Faculdade de Medicina, Universidade Federal do Ceara, Fortaleza, Ceara, Brazil. * Author for correspondence. E-mail:

Caption: Figure 1. EP-Mt edematogenic effect is inhibited by L-NAME and dexamethasone. EP-Mt (0.01, 0.1, 1 mg [kg.sup.-1]) was injected s.c. and the paw edema evaluated at zero time and from 30-420 min thereafter. (A) Edema time course (mL); (B) area under curve (AUC); (C) AUC of EP-Mt (1 mg [kg.sup.-1]) or EP-Mt + dexamethasone (5 mg [kg.sup.-1]; i.v.): evaluation from 30-240 min or; (D) EP-Mt + L-NAME (25 mg [kg.sup.-1]; i.v.): evaluation from 30-120 min. Mean [+ or -] S.E.M. (n = 6). One-way ANOVA and Bonferroni test. * p<0.05 vs. saline; # p<0.05 vs. 1 mg [kg.sup.-1] EP-Mt.

Caption: Figure 2. EP-Mt elicits leukocyte migration. Peritonitis was induced by EP-Mt (1 mg [kg.sup.-1]; i.p.) in animals (A) naive or treated 30 min before with (B) dexamethasone (Dexa, 5 mg [kg.sup.-1]; i.v.), L-NAME (25 mg [kg.sup.-1]; i.v.) or indomethacin (Indo, 10 mg [kg.sup.-1]; i.v). Total and differential leukocyte counts or (C) MPO activity was evaluated 180 min after peritonitis induction; Mean [+ or -] E.P.M. (n=6). Two-way ANOVA and Bonferroni. * p < 0.05 vs. saline; # p < 0.05 vs. EP-Mt.
Table 1. EP-Mt does not alter vascular permeability.

Models                 Control               EP-Mt

(a) Paw edema      4.5 [+ or  -] 0.2    3.8 [+ or  -] 1.7
(b) Peritonitis   10.4 [+ or  -] 0.4   10.0 [+ or  -] 0.4

(a) Evans Blue leakage ([micro]g Evans blue/g paw); (b) Bradford
method (mg [mL.sup.-1])
COPYRIGHT 2016 Universidade Estadual de Maringa
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2016 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:texto en ingles
Author:da Silva-Leite, Kaira Emanuella Sales; Queiroz, Cinthia Silva; Madeira, Juliana da Costa; Soares, Pe
Publication:Acta Scientiarum. Biological Sciences (UEM)
Date:Oct 1, 2016
Previous Article:Record and foraging behavior of ants (Hymenoptera, Formicidae) in vertebrate carcasses/Registro de forrageio de formigas (Hymenoptera, Formicidae) em...
Next Article:Protective effects of ethanolic extract from the red algae Amansia multifida on experimental inflammation, nociception and seizure experimental...

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters